Gene Query: GNPNAT1

Dataset Description Geneva Score
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 132.23
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 132.23
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 52.23
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 44.75
JunB control of keratinocyte-mediated inflammation [RNA-seq] 36.92
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 36.92
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 36.78
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 34.14
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 31.65
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 30.59
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 29.59
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 29.49
Role for citron kinase in prostate cancer growth 28.93
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 28.79
MYCi975 regulates MYC target genes 27.86
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 27.86
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 27.77
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 26.1
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 26.1
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 26.04
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 25.06
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 24.62
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 24.26
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 22.85
The landscape of alternative splicing in aggressive prostate cancers 22.19
A role for ZNF598 in post-transcriptional gene regulation 22.18
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 22.12
LNCaP treated with iBET 21.31
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 20.88
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 20.7
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 20.7
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 20.69
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 20.46
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 20.21
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 20.18
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 19.82
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 19.26
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 19.2
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 19.16
Functional role of CPPED1 in trophoblasts. 18.49
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 18.22
Cleavage Factor Im as a key regulator of 3’ UTR length 18.2
FOXD3 is a novel tumor suppressor in lung cancer 18.2
Transcriptome analysis of U87 cells upon LINC00152 knockdown 18.18
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 18.17
RIG-I and MDA5 fRIP during KSHV lytic reactivation 17.98
Global gene expression profile of dasatinib-resistant RCH-ACV cells 17.85
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 17.8
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 17.62
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 17.62
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 17.62
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 17.54
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 17.38
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 17.36
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 17.34
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 17.15
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 17.07
Paxillin regulates genomic networks in prostate cancer [LNCaP] 16.81
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 16.74
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 16.53
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 16.5
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 16.5
RNAseq of HEK293 cells after Chtop knockdown 16.22
Co-transcriptional loading of RNA export factors shapes the human transcriptome 16.22
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 16.21
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 16.12
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 16.05
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 15.9
Nrf2 regulated genes in A549 cells 15.76
Identification of Nrf2 regulated genes by RNA sequencing 15.76
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 15.67
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 15.58
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 15.44
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 15.23
Downregulation of DDX5/DDX17 and REST 15.07
Paxillin regulates genomic networks in prostate cancer [C4-2] 14.99
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 14.75
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 14.68
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 14.68
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 14.61
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 14.55
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 14.55
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 14.55
Nucleoporin-mediated regulation of cell identity genes 14.55
Gene expression profiling of human and murine in vitro muscle differentiation 14.49
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 14.4
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 14.4
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 14.37
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 14.11
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 14.04
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 13.98
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 13.96
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 13.93
RNAseq Analysis in glioblastoma cells treated with Mepazine 13.88
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 13.85
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.78
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 13.72
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 13.69
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 13.6
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 13.54
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 13.39
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 13.25
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 13.16
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 13.08
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 13.08
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 13.03
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 13.03
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 13.03
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 13.02
Effect of mitochondria deficiency on senescence-associated gene expression 12.97
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 12.93
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 12.7
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 12.62
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 12.6
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 12.54
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 12.32
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 12.29
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 12.29
METTL3 promotes translation in human cancer cells 12.13
Transcriptomic analysis of the HOTAIR-regulated genes 12.11
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 12.02
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 11.96
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 11.96
Cajal bodies are linked to genome conformation 11.95
Cajal bodies are linked to genome conformation [RNA-Seq] 11.95
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 11.94
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 11.94
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 11.93
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 11.91
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 11.91
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 11.9
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 11.9
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 11.88
Functional role of SLIT2 and ROBO1 in trophoblasts 11.85
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 11.77
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 11.75
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 11.74
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.73
Sensing self and nonself circular RNAs 11.73
Seletive inhibition of CDK9 in DLBCL cell lines 11.68
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 11.66
MYC dependent mRNA translation shapes gene expression and cell biology 11.62
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 11.61
Chromatin landscape of human visceral and subcutaneous adipocytes 11.44
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 11.41
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 11.36
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 11.29
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 11.26
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 11.22
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 11.17
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 11.17
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 11.09
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 11.07
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 11.07
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.97
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 10.96
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 10.89
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 10.84
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 10.78
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 10.77
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.72
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 10.7
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 10.65
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 10.54
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 10.53
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.51
Transcription control by the ENL YEATS domain in acute leukemia 10.49
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 10.49
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 10.47
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 10.46
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 10.42
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 10.42
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 10.41
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 10.41
Identification of global XBP1s target gene expression in human prostate cancer cells 10.37
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 10.37
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 10.35
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 10.29
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 10.27
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.2
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 10.15
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 10.15
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 10.1
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 10.1
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.06
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 10.03
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 10.03
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 10.03
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.02
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.0
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 9.99
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 9.97
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 9.97
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.96
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.9
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 9.9
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 9.9
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 9.88
Transcriptomic analyssis following EHMT1/2 inhibition 9.78
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 9.78
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 9.76
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 9.72
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 9.71
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.69
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.67
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 9.65
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 9.64
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 9.64
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 9.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.62
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 9.61
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.59
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 9.57
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 9.56
NRDE2 negatively regulates nuclear exosome functions 9.56
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 9.49
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 9.47
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 9.47
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 9.44
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 9.44
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 9.43
The cohesin complex prevents Myc-induced replication stress 9.42
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 9.38
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 9.36
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 9.33
TGF-β regulation of miRNA expression in pancreatic cancer 9.32
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.31
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 9.28
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.26
Genome wide expression change by RNF168 knocking down in NEC cells 9.26
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.2
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.19
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 9.17
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 9.15
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 9.1
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 8.98
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.98
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 8.87
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 8.86
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 8.86
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 8.79
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 8.78
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.77
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 8.74
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 8.72
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 8.72
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 8.65
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.64
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.63
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.61
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 8.57
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 8.57
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 8.45
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 8.45
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 8.43
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 8.4
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 8.37
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 8.34
3’ Uridylation Expands miRNA Target Repertoire 8.34
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.34
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 8.33
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 8.32
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 8.32
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.3
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 8.3
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.29
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.29
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 8.27
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 8.21
Identification of HOXB13 target genes responsive to BET inhibitors 8.18
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 8.17
PNET animal model: new insights (II) 8.14
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 8.13
Glioblastoma stem cells infected by ZIKA virus 8.12
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 8.11
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 8.09
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 8.04
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 8.03
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 8.03
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.02
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 8.01
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 8.0
Mapping interactions for the TNIP2 hub protein 7.99
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.97
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.97
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.93
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 7.91
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.83
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.83
Genome wide expression change in LCC2 and MCF-7 cells 7.81
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 7.8
Paxillin regulates genomic networks in prostate cancer [PC3] 7.75
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.73
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 7.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 7.7
CDK12 mediated transcriptional regulation in U2OS cells 7.67
IL-33 activates tumor stroma to promote intestinal polyposis 7.62
RNA-seq analysis of RALD iPSCs after in vitro differentiation 7.62
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 7.56
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 7.48
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 7.48
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.47
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 7.43
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.41
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.4
EGR1-controlled transcriptome of T HESCs 7.4
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 7.4
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 7.38
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 7.34
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 7.27
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 7.24
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.24
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 7.2
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.04
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.04
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 6.99
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.96
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 6.96
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.86
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 6.83
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.75
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 6.74
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 6.74
RNA-seq of RKO cells with cTAZ KO or putback 6.72
N6-methyladenine DNA Modification in Glioblastoma 6.69
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.69
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 6.66
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 6.61
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.52
SOX11 knockdown in B-ALL cell lines 6.5
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.41
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 6.39
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.38
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.38
RNA seq_PDX2_SHP099 6.33
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.29
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.29
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 6.29
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 6.26
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 6.26
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 6.22
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  6.14
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 6.12
Dynamic reorganization of nuclear architecture during human cardiogenesis 6.08
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 6.08
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 6.04
Transcriptional changes in lymphoma cells induced by LSD1 depletion 6.04
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 5.91
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 5.77
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 5.77
Effect of PRDM11 depletion in U2932 cells 5.77
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.7
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 5.65
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 5.65
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 5.64
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.64
Interaction between mitoNEET and NAF-1 in cancer cells 5.61
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.6
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.46
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 5.37
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.28
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 5.16
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.15
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.15
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.07
Zone dependent distinctive gene expression profile of the normal human liver tissue 5.02
AR-independent prostate cancer is sustained through FGF signaling 5.0
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 4.95
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 4.95
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.94
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.94
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.92
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 4.81
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 4.81
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.73
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.73
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.73
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.67
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.61
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 4.57
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.54
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.49
Mitochondrial dsRNA triggers antiviral signalling in humans 4.45
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 4.43
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.42
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.42
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 4.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.39
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.25
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.08
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 4.07
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.01
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.97
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.97
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.93
Gene expression profile in breast cancer cells 3.93
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.93
Transcriptome-wide modulation of splicing by the exon junction complex 3.75
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 3.7
Expression profiling of converted and control dermal BJ fibroblasts 3.7
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.69
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 3.66
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.6
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.56
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.5
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.49
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.42
O-glcnAc reprograms cellular energetics 3.39
CHD1 regulates cell fate determination by activation of differentiation-induced genes 3.33
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.31
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 3.26
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 3.26
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.25
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.23
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.06
Transcriptomic analysis of LSD1 3.05
p53 activity results in DNA replication fork processivity 3.04
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.96
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.96
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.72
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.65
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.64
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.61
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.61
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.58
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 2.57
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.53
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.47
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.41
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.39
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.39
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.33
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.31
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.26
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.25
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.18
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 2.13
Systematic discovery of endogenous human ribonucleoprotein complexes 2.12
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 2.11
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.08
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.08
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.89
The cohesin release factor WAPL restricts chromatin loop extension. 1.86
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.86
Random mono-allelic expression in MECP2-mutated cells 1.82
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.67
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.62
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.62
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.6
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.6
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.49
Genome-wide analysis of the Integrator complex (HTS) 1.47
Genome-wide analysis of the Integrator complex 1.47
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.46
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.45
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 1.43
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.38
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.38
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.37
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.32
Transposon-based construction of strand-specific RNA-seq libraries 1.3
6mer seed toxicity in viral microRNAs 1.26
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.21
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.14
Gene expression analysis of human liver progenitor-like cells in culture 1.12
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.11
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.11
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.04
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.04
Gene expression profile of CRC-derived HILEC 1.0
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.9
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.86
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.85
mRNA recovered upon RNF219 IP. [RNA-IP] 0.78
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.77
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.77
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.69
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.56
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.55
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.55
Interphase condensins regulate ligand-depedent enhancer activation 0.53
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.53
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.45
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.45
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.36
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.33
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.25
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.21
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.21
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.14
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.14
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.1
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.06
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.05
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.02
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.02
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation